Correlation Between Bluejay Diagnostics and BrainsWay

Can any of the company-specific risk be diversified away by investing in both Bluejay Diagnostics and BrainsWay at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bluejay Diagnostics and BrainsWay into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bluejay Diagnostics and BrainsWay, you can compare the effects of market volatilities on Bluejay Diagnostics and BrainsWay and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bluejay Diagnostics with a short position of BrainsWay. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bluejay Diagnostics and BrainsWay.

Diversification Opportunities for Bluejay Diagnostics and BrainsWay

-0.72

Correlation Coefficient

Bluejay Diagnostics  BrainsWay

Pay attention - limited upside

The 3 months correlation between Bluejay and BrainsWay is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Bluejay Diagnostics and BrainsWay in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BrainsWay and Bluejay Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bluejay Diagnostics are associated (or correlated) with BrainsWay. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BrainsWay has no effect on the direction of Bluejay Diagnostics i.e., Bluejay Diagnostics and BrainsWay go up and down completely randomly.

Pair Corralation between Bluejay Diagnostics and BrainsWay

Given the investment horizon of 90 days Bluejay Diagnostics is expected to under-perform the BrainsWay. In addition to that, Bluejay Diagnostics is 2.17 times more volatile than BrainsWay. It trades about -0.04 of its total potential returns per unit of risk. BrainsWay is currently generating about 0.13 per unit of volatility. If you would invest  210.00  in BrainsWay on September 1, 2024 and sell it today you would earn a total of  105.00  from holding BrainsWay or generate 50.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Bluejay Diagnostics  vs.  BrainsWay

Bluejay Diagnostics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Bluejay Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

BrainsWay

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in BrainsWay are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, BrainsWay reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bluejay Diagnostics and BrainsWay

The main advantage of trading using opposite Bluejay Diagnostics and BrainsWay positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bluejay Diagnostics position performs unexpectedly, BrainsWay can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BrainsWay will offset losses from the drop in BrainsWay's long position.

The idea behind Bluejay Diagnostics and BrainsWay pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.